Document is current
Any future updates will be listed below
-
Authors
Labro, Guylaine
Aptel, François
Puyraveau, Marc
Paillot, Jonathan
Pili Floury, Sébastien
Merdji, Hamid
Helms, Julie
Piton, Gaël
Ecarnot, Fiona
Kuteifan, Khaldoun
Quenot, Jean Pierre http://orcid.org/0000-0003-2351-682X
Capellier, Gilles
,
Navellou, Jean-Christophe
Chaignat, Claire
Grandperrin, Mathilde
Claveau, Mélanie
Belin, Nicolas
Patry, Cyrille
Claude, Frédéric
Belon, François
Barrot, Loïc
Colnot, Marion
Besch, Guillaume
Blasco, Gilles
Ginet, Marc
Brunin, Yannick
Andreu, Pascal
Dargent, Auguste
Charles, Pierre Emmanuel
Meziani, Ferhat
Monnier, Alexandra
Studer, Antoine
Clere-Jehl, Raphaël
Rahmani, Hassene
Dureau, Anne Florence
Poidevin, Antoine
Mootien, Joy
Bodur, Gokhan
Ionescu, Carmen
Guiot, Philippe
- License Information
-
More Information
Article History
Received: 27 June 2021
Accepted: 21 September 2021
First Online: 12 October 2021
Declarations
:
: The study received central approval for all study sites from the Ethics Committee Comité de Protection des Personnes (CPP) Est-II in April 2014 under the number 14/427, and from the French Agency for the Safety of Medications and Health Products (Agence Nationale de Sécurité du Médicament et des produits de santé, ANSM) under the number 2013-A01802-43. Since included patients were in a coma at the time of inclusion, their legal representative was informed about the study, and provided written informed consent. Patients were informed of their inclusion in the study and their written consent was obtained as soon as they regained capacity.
: Not applicable.
: The authors declare that they have no competing interests.
